References
- Genestier L., Paillot R., Fournel S., Ferraro C., Miossec P., Revillard J. P. Immunosuppressive properties of methotrexate: Apoptosis and clonal deletion of activated peripheral T cells. J Clin Invest 1998; 102: 322–8
- Calabrese L. H. Molecular differences in anticytokine therapies. Clin Exp Rheumatol 2003; 21: 241–8
- Pitarch G., Sanchez‐Carazo J. L., Mahiques L., Perez‐Ferriols M. A., Fortea J. M. Treatment of psoriasis with adalimumab. Clin Exp Dermatol 2007; 32: 18–22
- Menter A., Tyring S. K., Gordon K., et al. Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial. J Am Acad Dermatol 2008; 58(1): 106–15
- Papoutsaki M., Chimenti M. S., Costanzo A., et al. Adalimumab for severe psoriasis and psoriatic arthritis: An open‐label study in 30 patients previously treated with other biologics. J Am Acad Dermatol 2007; 57: 269–75
- Saurat J. H., Stingl G., Dubertret L., et al. Efficacy and safety results from the randomized controlled comparative study of adalimumab vs. methotrexate vs. placebo in patients with psoriasis (CHAMPION). Br J Dermatol 2008; 158(3): 549–57
- Bovenschen H. J., Seyger M. M., Van de Kerkhof P. C. Plaque psoriasis vs. atopic dermatitis and lichen planus: A comparison for lesional T‐cell subsets, epidermal proliferation and differentiation. Br J Dermatol 2005; 153: 72–8
- Vissers W. H., Arndtz C. H., Muys L., Van Erp P. E., de Jong E. M., Van de Kerkhof P. C. Memory effector (CD45RO+) and cytotoxic (CD8+) T cells appear early in the margin zone of spreading psoriatic lesions in contrast to cells expressing natural killer receptors, which appear late. Br J Dermatol 2004; 150: 852–9
- Bovenschen H. J., Gerritsen W. J., van Rens D. W., Seyger M. M., de Jong E. M., Van de Kerkhof P. C. Explorative immunohistochemical study to evaluate the addition of a topical corticosteroid in the early phase of alefacept treatment for psoriasis. Arch Dermatol Res 2007; 298: 457–63
- Langewouters A. M., Bovenschen J. H., de Jong E. M., Van Erp P. E., Van de Kerkhof P. C. The effect of topical corticosteroids in combination with alefacept on circulating T‐cell subsets in psoriasis. J Dermatolog Treat 2007; 18: 279–85